会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明公开
    • 동맥경화 진단, 예방 및 치료용 펩타이드 및 이의 용도
    • 用于诊断,预防和治疗甲状腺功能亢进的肽及其用途
    • KR1020080090610A
    • 2008-10-09
    • KR1020070033592
    • 2007-04-05
    • 경북대학교 산학협력단
    • 이병헌김인산홍해연소인섭
    • C07K7/00C07K7/06
    • G01N33/6893C07K7/06G01N2800/323
    • A peptide is provided to be used for diagnosing, preventing and treating arteriosclerosis by Rapamycin, Lovastatin, Celebrex or Ticlopin, preventing and treating inflammation reaction induced by IL-4, and be combined with a therapeutic material of the arteriosclerosis to prevent or treat the arteriosclerosis. A peptide comprises an amino acid sequence described as SEQ ID : NO. 1 or 2. A polynucleotide encodes the amino acid sequence and comprises a sequence described as SEQ ID : NO. 3 or 4. A transformant is transformed by an expression vector including the polynucleotide. A composition for diagnosing, preventing and treating arteriosclerosis comprises the peptide as an effective ingredient, wherein the peptide is labeled with peroxidase, alkaline phosphatase, I^124, I^125, In^111, Tc^99m, P^32, S^35, chromophore, biotin, FITC(fluorescein isothiocyanate), RITC(rhodamine isothiocyanate), rhodamine, Texas Red, fluorescein, phycoerythrin, quantum dots, superparamagnetic iron oxides(SPIO), or ultrasuperparamagnetic iron oxides(USPIO).
    • 提供了一种肽,用于诊断,预防和治疗雷帕霉素,洛伐他汀,塞来昔布或噻氯林的动脉硬化,预防和治疗由IL-4引起的炎症反应,并与动脉硬化的治疗材料组合以预防或治疗动脉硬化 。 肽包含SEQ ID NO:1所示的氨基酸序列。 多核苷酸编码氨基酸序列并包含SEQ ID NO:1所示的序列。 3或4.转化体由包含多核苷酸的表达载体转化。 用于诊断,预防和治疗动脉硬化的组合物包含该肽作为有效成分,其中肽用过氧化物酶,碱性磷酸酶,I ^ 124,I ^ 125,In 111,Tc 99m,P ^ 32,S ^ 35,发色团,生物素,FITC(异硫氰酸荧光素),RITC(异硫氰酸罗丹明),罗丹明,德克萨斯红,荧光素,藻红蛋白,量子点,超顺磁性氧化铁(SPIO)或超顺铂铁氧化物(USPIO)。
    • 8. 发明公开
    • 활성 폴리펩타이드의 결합 친화력 및 결합 특이성을 증강시키는 단백질 골격 모듈
    • 设计的模块化免疫组化的发展与应用
    • KR1020120118186A
    • 2012-10-26
    • KR1020110035613
    • 2011-04-18
    • 경북대학교 산학협력단
    • 차기원소인섭김소연이병헌김인산
    • C07K14/705C12N15/12G01N33/68
    • C07K14/485C07K14/47C07K14/5406C07K14/705C07K2319/00G01N33/68
    • PURPOSE: A protein skeleton module is provided to enhance binding affinity or binding specificity of active polypeptide, thereby being effective for diagnosis and treatment of diseases. CONSTITUTION: A protein skeleton module in which active polypeptide is embedded comprises polypeptide consisting of first to nineteenth amino acid sequence described in the sequence number 1, polypeptide including the active polypeptide, and polypeptide in which the polypeptides consisting of 29th-86th amino acid sequence described in the sequence number 1 are successively connected. The expression vector includes polynucleotide which codes the protein skeleton module in which the active polypeptide is embedded. A manufacturing method of the active polypeptide comprises a step of cultivating a host cell transformed to the expression vector. The composition for diagnosis includes the protein skeleton module in which the active polypeptide is embedded as an active ingredient.
    • 目的:提供蛋白骨架模块以增强活性多肽的结合亲和力或结合特异性,从而有效地诊断和治疗疾病。 构成:其中嵌入活性多肽的蛋白质骨架模块包含由序列号1中描述的第一至第十九个氨基酸序列,包括活性多肽的多肽和多肽组成的多肽,其中由所述第29-86位氨基酸序列组成的多肽 在序列号1中连续连接。 表达载体包括编码其中嵌入活性多肽的蛋白质骨架模块的多核苷酸。 活性多肽的制造方法包括培养转化到表达载体的宿主细胞的步骤。 用于诊断的组合物包括嵌入活性多肽作为活性成分的蛋白质骨架模块。